These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6990180)

  • 1. Role of insulin receptors in insulin-resistant states.
    Kahn CR
    Metabolism; 1980 May; 29(5):455-66. PubMed ID: 6990180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance in non-insulin dependent (type II) and insulin dependent (type I) diabetes mellitus.
    Olefsky JM; Revers RR; Prince M; Henry RR; Garvey WT; Scarlett JA; Kolterman OG
    Adv Exp Med Biol; 1985; 189():176-205. PubMed ID: 3898763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin receptors in normal and disease states.
    Grunberger G; Taylor SI; Dons RF; Gorden P
    Clin Endocrinol Metab; 1983 Mar; 12(1):191-219. PubMed ID: 6342876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of insulin resistance in the pathogenesis of diabetes mellitus].
    Reaven GM
    Medicina (B Aires); 1978; 38(5):577-86. PubMed ID: 368502
    [No Abstract]   [Full Text] [Related]  

  • 5. Obesity and insulin resistance in Swedish subjects.
    Arner P
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S85-6. PubMed ID: 8894488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The insulin resistance of acromegaly: evidence for two alterations in the insulin receptor on circulating monocytes.
    Muggeo M; Bar RS; Roth J; Kahn CR; Gorden P
    J Clin Endocrinol Metab; 1979 Jan; 48(1):17-25. PubMed ID: 422699
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin-receptor autophosphorylation and endogenous substrate phosphorylation in human adipocytes from control, obese, and NIDDM subjects.
    Thies RS; Molina JM; Ciaraldi TP; Freidenberg GR; Olefsky JM
    Diabetes; 1990 Feb; 39(2):250-9. PubMed ID: 2227134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insulin receptor and postreceptor disorders: significance for the development and therapy of carbohydrate metabolic disorders].
    Schernthaner G; Prager R
    Acta Med Austriaca; 1984; 11(3-4):70-8. PubMed ID: 6382903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes.
    Olefsky JM; Garvey WT; Henry RR; Brillon D; Matthaei S; Freidenberg GR
    Am J Med; 1988 Nov; 85(5A):86-105. PubMed ID: 3057897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of insulin receptors in the pathogenesis and treatment of diabetes].
    Lenti G; Pagano G; Cassader M
    Journ Annu Diabetol Hotel Dieu; 1978; ():73-86. PubMed ID: 349230
    [No Abstract]   [Full Text] [Related]  

  • 11. Cellular alterations responsible for insulin resistance in obesity and type II diabetes mellitus.
    Lockwood DH; Amatruda JM
    Am J Med; 1983 Nov; 75(5B):23-31. PubMed ID: 6369965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of insulin receptors in insulin resistance.
    Gliemann J; Beck-Nielsen H; Pedersen O; Sonne O
    Ann Clin Res; 1980 Oct; 12(5):264-8. PubMed ID: 7015987
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of insulin receptors in normal and abnormal physiology in humans.
    Bar RS; Harrison LC; Muggeo M; Gorden P; Kahn CR; Roth J
    Adv Intern Med; 1979; 24():23-52. PubMed ID: 218432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin receptors and insulin resistance.
    Flier JS
    Annu Rev Med; 1983; 34():145-60. PubMed ID: 6344753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulin resistance in pituitary, thyroid, and adrenal diseases].
    Iitaka M; Katayama S
    Nihon Rinsho; 2000 Feb; 58(2):451-5. PubMed ID: 10707575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance in non-insulin-dependent, type II diabetes mellitus.
    Kolterman OG; Scarlett JA; Olefsky JM
    Clin Endocrinol Metab; 1982 Jul; 11(2):363-88. PubMed ID: 6754161
    [No Abstract]   [Full Text] [Related]  

  • 17. [Insulin resistance. Physiopathological and biochemical aspects].
    Freychet P
    Ann Endocrinol (Paris); 1984; 45(2):107-14. PubMed ID: 6391363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New data in the domain of insulin resistance].
    Freychet P
    Sem Hop; 1977 Jun; 53(24):1421-4. PubMed ID: 197631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptors, antireceptor antibodies and mechanisms of insulin resistance.
    Flier JS; Kahn CR; Roth J
    N Engl J Med; 1979 Feb; 300(8):413-9. PubMed ID: 366414
    [No Abstract]   [Full Text] [Related]  

  • 20. Alterations in insulin binding induced by changes in vivo in the levels of glucocorticoids and growth hormone.
    Kahn CR; Goldfine ID; Neville DM; De Meyts P
    Endocrinology; 1978 Oct; 103(4):1054-66. PubMed ID: 217665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.